loader

World Tenders & Procurement Opportunities

Abschluss eines nicht-exklusiven Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Apomorphin hydrochlorid, ATC-Code: N04BC07, für die Zeit vom 15.2.2020 bis zum 31.7.2020

World Biggest Tenders Source

This tender with title Abschluss eines nicht-exklusiven Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Apomorphin hydrochlorid, ATC-Code: N04BC07, für die Zeit vom 15.2.2020 bis zum 31.7.2020 has been published on Bidding Source portal dated 28 Jan 2020 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Abschluss eines nicht-exklusiven Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Apomorphin hydrochlorid, ATC-Code: N04BC07, für die Zeit vom 15.2.2020 bis zum 31.7.2020
Contract notice
2020/S 019-041197
Germany
Germany-Aachen
28 Jan 2020
5 Jun 2020
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

745526- Germany – Pharmaceutical products – Drug rebate agreements from 01.01.2026 for various active ingredients within the framework of an open-house procedure Germany 743721- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient triptorelin (ATC code: L02AE04 and H01CA07). Germany 744652- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient pazopanib (ATC code: L01EX03). Germany 746904- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient ranibizumab (ATC code: S01LA04). Germany 747573- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the aforementioned active ingredients, with the option of concluding such agreements within the framework of the so-called open-house procedure. Germany 740409- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient tiapride (WHO ATC code: N05AL03) Germany 739760- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient pazopanib (WHO ATC code: L01EX03) Germany 741238- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient dimethyl fumarate (official ATC code: L04AX07) Germany 730881- Germany – Pharmaceutical products – Open-House-Verträge 2025-4 Germany 730623- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the aforementioned active ingredients, with the option of concluding such agreements within the framework of the so-called open-house procedure. Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans